Author

Pingchao Li

Chinese Academy of SciencesORCID 0000-0001-5046-0855Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Ling CheniD· 2 shared An Hong· 1 shared Caijun SuniD· 1 shared Chenchen YangiD· 1 shared Chunhua Wang· 1 shared Congcong WangiD· 1 shared Haohang Wang· 1 shared Hengchun LiiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ling ChenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 26, 2026

An oncolytic adenovirus armed with anticancer prodrug-activating enzyme offers enhanced tumor killing and antitumor immunity.

Mengshi Sun, Suhua Guan, Chenchen Yang…·Ling Chen

This study develops an oncolytic adenovirus that activates a prodrug to enhance tumor killing and antitumor immunity through direct oncolysis, bystander effects, and systemic immune responses.

DOI 10.64898/2026.05.26.727470

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivFeb 20, 2024

Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques

Ziyu Wen, Pingchao Li, Yue Yuan…·Caijun Sun

This study develops a HSV-vectored therapeutic vaccine that reactivates SIV latency and elicits immune responses, delaying viral rebound in SIV-infected macaques.

7 citations

non-human primateexperimental assay

𝕏 PostBluesky